← Leaderboards
Friedbert Weiss
Scripps Research Institute, The
$29,892,668
Attributed
$29,892,668
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,892,668 · 13
By mechanism
R01$22,986,939 · 8
R37$3,793,105 · 1
R21$1,685,765 · 3
P60$1,426,859 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Marisa Roberto$41,318,569
- Claes Robert Wahlestedt$16,919,962
- Cindy L Ehlers$40,659,001
- John Robert Yates$49,942,444
- Barbara J Mason$35,175,467
Others in their field
Top investigators on “Neurobiology”
- David A Bennett · Rush University Medical Center$71,348,395
- Paul S. Aisen · Cognition Therapeutics, Inc.$66,819,733
- Charles W Roberts · St. Jude Children'S Research Hospital$63,699,748
- Carol D. Ryff · University Of Wisconsin Madison$62,299,469
- Jane S Paulsen · University Of Wisconsin-Madison$49,909,067
- Raquel E Gur · University Of Pennsylvania$44,438,681
Research focus
NeurobiologyRelapseCuesPharmaceutical PreparationsBehaviorBehavioralEthanolRattusChronicRecording Of Previous EventsStimulusMediatingBrainBaseSiteAnimal ModelCravingRelating To Nervous SystemReceptorDesignBrain RegionCocaineStressMotivated Behavior
Grant awards (87)
The Nociceptin ORL1 System: Treatment Target for Relapse$346,968
R01 · FY2025 · AA · contact PI
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history$404,403
R01 · FY2024 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$346,968
R01 · FY2024 · AA · contact PI
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history$396,978
R01 · FY2023 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$342,864
R01 · FY2023 · AA · contact PI
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history$396,995
R01 · FY2022 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$355,514
R01 · FY2022 · AA · contact PI
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history$399,720
R01 · FY2021 · AA · contact PI
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history$411,651
R01 · FY2020 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$360,734
R01 · FY2020 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$360,734
R01 · FY2019 · AA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$364,252
R01 · FY2018 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$360,734
R01 · FY2018 · AA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$364,277
R01 · FY2017 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$360,734
R01 · FY2017 · AA · contact PI
Cannabidiol: Lasting attenuation of ethanol seeking$180,469
R21 · FY2017 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$125,775
R01 · FY2017 · AA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$124,121
R01 · FY2017 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$380,169
R01 · FY2016 · AA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$364,303
R01 · FY2016 · AA · contact PI
Cannabidiol: Lasting attenuation of ethanol seeking$324,844
R21 · FY2016 · AA · contact PI
Implementation of novel methodology to study the anti-relapse potential of cannabidiol$190,575
R21 · FY2016 · DA · contact PI
Implementation of novel methodology to study the anti-relapse potential of cannabidiol$173,250
R21 · FY2016 · DA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$353,398
R01 · FY2015 · AA · contact PI
Implementation of novel methodology to study the anti-relapse potential of cannabidiol$331,625
R21 · FY2015 · DA · contact PI
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol$382,255
R01 · FY2014 · AA · contact PI
The nociceptin ORL1 System: Treatment Target for Relapse$366,101
R01 · FY2014 · AA · contact PI
Novel Treatments for Cocaine Dependence$393,900
R37 · FY2013 · DA · contact PI
The nociceptin ORL1 System: Treatment Target for Relapse$351,005
R01 · FY2013 · AA · contact PI
Significance of withdrawal-related learning in EtOH craving and relapse$165,221
R21 · FY2013 · AA · contact PI
Novel Treatments for Cocaine Dependence$410,313
R37 · FY2012 · DA · contact PI
Novel methods to explore mechanisms of cocaine abuse$409,449
R01 · FY2012 · DA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$383,192
R01 · FY2012 · AA · contact PI
The nociceptin ORL1 System: Treatment Target for Relapse$377,424
R01 · FY2012 · AA · contact PI
Significance of withdrawal-related learning in EtOH craving and relapse$319,781
R21 · FY2012 · AA · contact PI
Novel Treatments for Cocaine Dependence$410,313
R37 · FY2011 · DA · contact PI
Novel methods to explore mechanisms of cocaine abuse$409,449
R01 · FY2011 · DA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$383,192
R01 · FY2011 · AA · contact PI
The nociceptin ORL1 System: Treatment Target for Relapse$377,424
R01 · FY2011 · AA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$76,499
R01 · FY2011 · AA · contact PI
Novel Treatments for Cocaine Dependence$423,002
R37 · FY2010 · DA · contact PI
Novel methods to explore mechanisms of cocaine abuse$422,111
R01 · FY2010 · DA · contact PI
The nociceptin ORL1 System: Treatment Target for Relapse$414,010
R01 · FY2010 · AA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$398,661
R01 · FY2010 · AA · contact PI
Novel Treatments for Cocaine Dependence$427,275
R37 · FY2009 · DA · contact PI
Novel methods to explore mechanisms of cocaine abuse$426,375
R01 · FY2009 · DA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$402,688
R01 · FY2009 · AA · contact PI
Neurochemical Basis of Ethanol-Seeking Behavior$314,441
R01 · FY2009 · AA · contact PI
Novel methods to explore mechanisms of cocaine abuse$426,375
R01 · FY2008 · DA · contact PI
Neural Substrates of Compulsive Ethanol-Seeking Behavior$402,688
R01 · FY2008 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$349,121
R01 · FY2008 · AA · contact PI
Novel Treatments for Cocaine Dependence$348,827
R37 · FY2008 · DA · contact PI
Dysregulation of Brain Stress Systems and of Relapse$348,827
R01 · FY2008 · DA · contact PI
Neurochemical Basis of Ethanol-Seeking Behavior$314,441
R01 · FY2008 · AA · contact PI
Novel Treatments for Cocaine Dependence$355,947
R37 · FY2007 · DA · contact PI
Dysregulation of Brain Stress Systems and of Relapse$355,947
R01 · FY2007 · DA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$346,391
R01 · FY2007 · AA · contact PI
Neurochemical Basis of Ethanol-Seeking Behavior$308,468
R01 · FY2007 · AA · contact PI
NEUROPHARMACOLOGY RESEARCH PROJECT$300,659
P60 · FY2007 · AA · contact PI
Novel Treatments for Cocaine Dependence$366,578
R37 · FY2006 · DA · contact PI
Dysregulation of Brain Stress Systems and of Relapse$366,578
R01 · FY2006 · DA · contact PI
Neurochemical Basis of Ethanol-Seeking Behavior$363,063
R01 · FY2006 · AA · contact PI
The Nociceptin ORL1 System: Treatment Target for Relapse$356,735
R01 · FY2006 · AA · contact PI
NEUROPHARMACOLOGY RESEARCH PROJECT$281,550
P60 · FY2006 · AA · contact PI
Neurochemical Basis of Ethanol-Seeking Behavior$386,143
R01 · FY2005 · AA
Dysregulation of Brain Stress Systems and of Relapse$375,400
R01 · FY2005 · DA
The Nociceptin ORL1 System: Treatment Target for Relapse$365,320
R01 · FY2005 · AA
Novel Treatments for Cocaine Dependence$328,475
R37 · FY2005 · DA
NEUROPHARMACOLOGY RESEARCH PROJECT$281,550
P60 · FY2005 · AA
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE$416,700
R01 · FY2004 · DA
The Nociceptin ORL1 System: Treatment Target for Relapse$387,245
R01 · FY2004 · AA
Dysregulation of Brain Stress Systems and of Relapse$375,400
R01 · FY2004 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$372,241
R01 · FY2004 · AA
Novel Treatments for Cocaine Dependence$328,475
R37 · FY2004 · DA
NEUROPHARMACOLOGY RESEARCH PROJECT$281,550
P60 · FY2004 · AA
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE$416,700
R01 · FY2003 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$370,993
R01 · FY2003 · AA
NEUROPHARMACOLOGY RESEARCH PROJECT$281,550
P60 · FY2003 · AA
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE$416,700
R01 · FY2002 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$369,776
R01 · FY2002 · AA
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE$398,925
R01 · FY2001 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$310,275
R01 · FY2001 · AA
NOVEL TREATMENTS FOR COCAINE DEPENDENCE$251,106
R01 · FY2001 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$42,593
R01 · FY2001 · AA
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE$398,925
R01 · FY2000 · DA
NEUROCHEMICAL BASES OF ETHANOL-SEEKING BEHAVIOR$334,502
R01 · FY2000 · AA
NOVEL TREATMENTS FOR COCAINE DEPENDENCE$243,793
R01 · FY2000 · DA